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Abstract 
The goal of this project was to provide empiric 
evidence about the benefit to US veterans and the VA 
of capturing data from a citywide clinical informatics 
network (INPC) to assess care received outside the 
VA.  We identified 468 veterans diagnosed with 
colorectal cancer from 2000-2007 in the 
Indianapolis VA cancer registry.  Electronic VA 
healthcare data were linked with electronic health 
records from the regional health information 
organization (RHIO) INPC; 341 matches were found. 
Both the VA and INPC systems were queried 
regarding receipt of surveillance tests.  The 
proportion with additional data from INPC varied by 
test:  colonoscopy (3%), CT scan/abdomen (13%), 
CT scan/chest (79%), carcinoembryonic antigen test 
(8%), and other laboratory tests (25%-53%).  An 
incremental benefit of linking VA and INPC data was 
present and may increase when expanded beyond 
patients with a single condition.  New, important 
information about care outside the VA is obtained 
through RHIO data linkage. 
Introduction 
Data linkages of health care information have often 
been of significant value to medical researchers and 
clinicians.  Creative linkages enable the connection of 
sets of data which taken together provide information 
that neither source of data can alone.  In cancer 
research, cancer registry data have been linked with 
administrative claims data from both private1 and 
public payors2 to understand more about the health 
care services delivered to cancer patients.  The most 
widely used such linkage is the Surveillance 
Epidemiology and End Results (SEER)-Medicare 
database.  Data from the VA has also been linked 
with Medicare data to enable better ascertainment of 
care delivered to veterans outside the VA, given that 
many veterans are dually eligible for Medicare and 
VA services.3  Limitations of such data include the 
fact that not all veterans meet age eligibility 
requirement for Medicare services. 
As the largest integrated delivery system in the United 
States, the VA has been recognized as a leader in 
developing a more coordinated system of care. 
Beginning in the early 1990s, VA leadership
instituted both an advanced electronic health record 
system and a quality improvement approach that 
holds regional managers accountable for multiple 
performance measures. 
Meanwhile, the Regenstrief Institute, Inc., has 
developed the Indiana Network for Patient Care 
(INPC), a secure operational citywide RHIO 
organized by patient in order to enhance clinical care 
and foster quality of care improvement and research 
in Indianapolis.4  The INPC maintains clinical data 
from public health departments, local laboratories, 
imaging centers, large group practices associated with 
hospitals, and more than 35 hospitals across Indiana. 
Clinical data about individual patients can be 
aggregated into a single virtual medical record.  For 
this study, we used INPC data from the five major 
hospital systems in the Indianapolis metropolitan 
area. Together they generate 2.7 million outpatient 
visits per year.  The Indianapolis VA is the only 
major healthcare system in Indianapolis which does 
not participate in the INPC. 
The creation of a VA-INPC data link in order to more 
fully capture care delivered to veterans in the 
community is potentially very important for multiple 
reasons.  First, obtaining information from outside the 
VA may improve the quality of care delivery for the 
individual, such as ensuring better communication 
between providers, enabling a system-wide view of 
quality, and reducing the risk of undergoing multiple 
imaging tests.  Second, the identification of redundant 
testing services may improve efficiency and reduce 
the cost of care.  In addition, including the 
measurement of care delivered in the community 
would inform both health services research, as well as 
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many clinical research studies.  Finally, whereas all 
VA medical centers (VAMCs) are evaluated based 
upon quality of care performance measures, we have 
the potential to demonstrate the benefit to the VA of 
capturing previously unmeasured care that occurs in 
the community. 
For example, gaps in evidence-based care have been 
documented for CRC survivors nationally both in the 
VA5 and community practice.6  Approximately 2,200 
veterans are diagnosed with CRC each year.7  Three 
recent high-quality meta-analyses reported a 20%-
33% relative risk reduction of all-cause mortality (7% 
absolute risk reduction) for individuals who received 
more intensive follow-up after primary treatment for 
CRC.8-10  These follow-up programs include periodic  
colonoscopy procedures, liver imaging (including CT 
scans), and blood carcinoembryonic antigen (CEA) 
testing.  Clinical guidelines from the American 
Society of Clinical Oncology also changed in 
November 2005 to recommend annual CT of the 
abdomen/chest for the first time.11  Furthermore, 
American Society of Clinical Oncology (ASCO) 
guidelines also outline tests that are not recommended 
for routine surveillance, including complete blood 
counts (CBCs) and liver function tests (LFTs).  Of 
note, both guideline-concordant and non-guideline 
concordant surveillance tests may sometimes be done 
for diagnostic purposes among patients with signs or 
symptoms of cancer recurrence. 
The overall goal of this project was to evaluate the 
feasibility and value of linking VA and RHIO data, in 
order to provide empiric evidence about the benefit of 
capturing data from veterans seen in community 
health care systems.  The specific aim was to 
determine whether assessments of CRC surveillance 
received by US veterans cared for at the Indianapolis 
VA would change when considering care received 
outside the VA, in the greater Indianapolis area.  To 
meet this aim, we created a VA-INPC dataset, linking 
a cohort of patients diagnosed with CRC at the 
Indianapolis VA to additional health care data from 
the INPC.  CRC care delivered inside the VA was 
assessed using the Indianapolis VA cancer registry 
and electronic medical record (VISTA) data, while 
care delivered outside the VA was assessed using 
data from the INPC. 
Methods 
Study Population:  We identified patients with 
incident colorectal cancer cared for at the 
Indianapolis VAMC and diagnosed from 2000-2007.  
A total of 468 individuals were identified in the 
Indianapolis VA cancer registry.  Patients with pre-
existing tumors were excluded. 
Approval Process:  We developed data security and 
data use agreements, reviewed and approved by 
review boards of both organizations.  The study was 
approved by the Indiana University-Purdue 
University Indianapolis Institutional Review Board, 
the Indianapolis VA Medical Center Research 
Committee, and the INPC Management Committee. 
Data linkage:  We then linked identifiers from VA 
CRC patients to identifiers from individuals receiving 
care in the INPC. 
The VA-INPC linkage was performed using a 
deterministic linkage, using an exact match of social 
security number (SSN) for the initial potential match:  
335 matches were found (72% of the original VA 
sample).  The VA-INPC linkage created no multiple 
matches (i.e., scenarios in which a single record from 
the VA matched multiple records from the INPC).  
Individuals were considered a match if there was 
complete agreement on 3 or more of the following 
(SSN, first name, last name, date/month/year of 
birth).  For all of these initial putative matches, two 
investigators independently reviewed last name, first 
name, and date of birth to confirm the 
appropriateness of the match; during this process, 12 
imperfect (probabilistic) matches that had a 
reasonable match with 3 of the above parameters 
(SSN, first name, last name, date/month/year of birth) 
were identified and one individual was excluded. 
The VA-INPC linkage was then performed a second 
time using a combination of the same last name (first 
6 positions), same first name (first 6 positions), and 
month of birth:  7 additional matches were found, for 
a total of 341 matches.  After the second linkage, in 
order to be considered a match, one of the following 
conditions was required:  agreement on 7 or 8 digits 
of the SSN or agreement on 2 or more of the 
following:  year of birth, day of birth, or middle 
initial.  The two investigators independently reviewed 
and confirmed the appropriateness of the additional 
potential matches.  This data linkage method was 
unique to this study and does not represent the 
methodology used across actively participating INPC 
institutions. 
Data sources:  We queried the following data from 
the INPC:  demographic file, procedures 
(colonoscopy), imaging (CT scans), and laboratory 
results.  In the VA system, we queried the VA cancer 
registry and electronic medical record (VISTA) data, 
which contains information on demographics, 
diagnoses, procedures, and laboratory tests, from both 
inpatient and outpatient settings.  VA surveillance 
data was collected within one year after diagnosis due 
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to feasibility.  No time limit was set upon the interval 
over which INPC data was gathered. 
Measures:  We measured the receipt of the following 
types of guideline-concordant surveillance tests:  
colonoscopy, CEA tests, chest CT, and abdomen 
(with or without pelvis) CT.  We also measured the 
following non-guideline concordant surveillance 
laboratory tests:  CBCs (including at least serum 
hemoglobin) and LFTs (either alkaline phosphatase, 
SGOT, SGPT, or serum bilirubin). 
Data Analysis: Demographic and clinical 
characteristics of the study population with CRC 
identified in the Indianapolis VA cancer registry are 
provided.  Descriptive statistics of the VA-INPC 
linkage dataset are reported at both the patient and the 
test level; a single patient could receive more than 
one test.  The number and proportion of (a) patients 
and (b) tests with surveillance data from VA data 
alone, both VA and INPC data, and INPC data alone 
are described.  Finally, we calculated the additional 
value of INPC data by dividing the number of 
patients for whom INPC data was available 
(numerator) by the number of patients or tests for 
whom some type of electronic data (VA or INPC) 
was available. 
Results 
Study population:  The mean age of the CRC patients 
was 67 years.  Most were male (96%), and 11% were 
African-American.  These sociodemographics were 
comparable to those receiving care in VAMCs in the 
Midwest.  Most CRC patients had adenocarcinoma 
(86%).  The pathologic cancer stage distribution of 
the study population was as follows:  Stage I (23%), 
Stage II (16%), Stage III (22%), Stage IV (16%), and 
unknown (22%).   
The receipt of different surveillance tests from 
different data sources varies by test (Table).  The 
proportion of patients who received tests from a given 
data source(s) was usually similar to the proportion of 
tests from a given data source(s), although the 
distribution could differ.  For example, across the 
denominator of all patients who received LFT lab 
tests, 47% of patients had their tests identified in VA 
data alone, 46% in INPC data alone, and 7% in both 
VA and INPC data.  Across the denominator of all 
LFT lab tests collected, 21% of tests were identified 
in VA data alone, 71% in INPC data alone, and 8% in 
both VA and INPC data. 
Additional value of INPC data:  The additional value 
of the linked INPC data varied by type of test.  The 
proportion of the study population with additional 
data from the INPC by test were the following:  
colonoscopy (3%), CT scan/abdomen (13%), CT 
scan/chest (79%), CEA test (8%), CBCs (25%), and 
LFTs (53%).  At the test level, the proportion of all 
tests that came from the INPC were the following:  
colonoscopy (3%), CT scan/abdomen (13%), CT 
scan/chest (86%), CEA test (6%), CBCs (28%), LFTs 
(79%). 
Discussion 
Our study demonstrates that data linkage of VA 
patient records with their records from outside the 
VA at health care organizations represented in a 
citywide RHIO is both feasible and informative.  New 
clinical and performance information is obtained 
about care received by veterans that cannot be 
obtained from VA administrative, EHR and electronic 
registry data alone.  An incremental benefit of linking 
# of patients (% of pts receiving 
test from data source) 
# of surveillance tests (% of tests 
received from data source) 
Surveillance test 
categories 
VA data 
alone 
 
both VA 
and INPC 
data  
INPC 
data 
alone 
Total 
patients 
(% of 
eligible) 
VA data 
alone 
both VA 
and INPC 
data  
INPC 
data 
alone 
Total 
tests 
Procedure and imaging tests 
Colonoscopy 150 
(97%) 
4 
(3%) 
0 
 
154 
 
190 
(97%) 
5 
(3%) 
0 
 
195 
 
CT scan 
(abdomen) 
202 
(87%) 
17 
(7%) 
12 
(5%) 
231 
 
369 
(87%) 
40 
(9%) 
16 
(4%) 
425 
 
CT scan (chest) 4 
(21%) 
0 
 
15 
(79%) 
19 
 
4 
(14%) 
0 
 
25 
(86%) 
29 
 
Lab tests 
Carcinoembryonic 
antigen (CEA) test 
196 
(92%) 
10 
(5%) 
6 
(3%) 
212 
 
524 
(95%) 
23 
(4%) 
12 
(2%) 
559 
 
Complete blood 
count (CBC) test 
223 
(75%) 
49 
(17%) 
24 
(8%) 
296 
 
1823 
(72%) 
416 
(16%) 
286 
(11%) 
2525 
 
Liver function test 
(LFT) test 
45 
(47%) 
7 
(7%) 
44 
(46%) 
96 
 
62 
(21%) 
24 
(8%) 
206 
(71%) 
292 
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VA and INPC data was present, varied by the test of 
interest, and may increase when expanded beyond 
patients with a single condition and as INPC data 
capture increases. 
The additional value of INPC (RHIO) data varied by 
type of surveillance test.  Differences in care 
measured outside the VA may vary either because of 
the nature of the way clinical data are collected or 
because of the actual health care received.  The INPC 
made the greatest relative contribution to data 
regarding laboratory tests, perhaps because these data 
were captured directly from central laboratories 
serving multiple hospitals, thus resulting in more 
complete data collection.  Furthermore, an inpatient 
hospitalization outside the VA,12 involving daily 
routine laboratory tests (CBCs and LFTs), may 
increase the proportion of laboratory tests collected 
outside the VA substantially.  Colonoscopy tests may 
be underrepresented in INPC due to their delivery in 
freestanding endoscopy facilities that may not share 
data with hospital information systems integrated into 
the INPC.  The one-year time interval over which VA 
data was collected may also have depressed the 
proportion of eligible patients who received 
colonoscopy among our cohort (33%).  In either case, 
veterans likely receive care not captured by our 
methods given the higher receipt colonoscopy among 
colorectal cancer survivors in previous studies (55-
64%, over varying time intervals).13-15 
According to a previous study of veterans,3 for 
outpatient service use, 18% were VA-only users, 36% 
were Medicare-only users, and 46% were both VA 
and Medicare users.  Among veterans with inpatient 
use, 24% were VA only, 69% were Medicare only, 
and 6% were both VA and Medicare users.  With the 
VA-INPC data linkage, we discovered less use of 
surveillance care outside the VA.  One key 
explanation for this may be selection bias, that is, our 
initial cohort of patients was identified in the VA 
cancer registry, and patients identified in this manner 
may be more likely to receive all or most of their care 
in the VA. 
The value of additional RHIO data may vary by 
health condition and will be greater, in absolute 
terms, when more patients are included in the linkage.  
For example a data linkage involving more types of 
cancer or a higher prevalence disease, such as 
diabetes, may provide a greater increase in additional 
information.  We did not examine the value of 
obtaining data from INPC specifically for those with 
an Indianapolis or Marion county address, although 
limiting the analyses to those residing in the city of 
Indianapolis would likely have shown higher rates of 
additional information.  On the other hand, the 
differing time frames over which data was collected 
from INPC (no limit) and the VA (one year) may 
have raised the relative proportion of additional 
information found outside the VA. 
From the perspective of VA operational leadership, 
any additional data capture of care received from 
INPC institutions outside the VA is greater 
operational knowledge than was present before, and 
therefore, an improvement. Given the VA’s 
commitment to “providing the best care anywhere”, 
this study may furnish evidence of the value of data 
sharing with RHIOs to both deliver more 
comprehensive care in the community and the VA, as 
well as more complete estimates of performance 
across both settings.  From both the INPC and VA 
perspective, striking the right balance between 
community data exchange – for clinical care, research 
and public health – and patient and institutional 
privacy considerations will be of ongoing importance.  
The approach outlined in this study used human 
review; in order to scale this project to substantially 
increase the amount of data available, more advanced 
approaches would be necessary, but are certainly 
available, to perform high volume record matching.16 
Future directions in the use of this type of data 
linkage include further characterization of how the 
use of data from multiple health care systems 
influences the operational functions of participating 
health care organizations.  Notably, the addition of 
RHIO data may influence assessment of the quality of 
care delivered to veterans.  Pooled results of the 
economic impact across patients and tests may also 
allow the VA and outside organizations to reduce 
redundancy and realize potential cost savings for both 
the health care system and patient.  Including data on 
tests obtained within the community may correctly 
account for those individuals who refuse to be tested 
again within the VA, when the test was already 
obtained and documented in the community. In 
addition, the incorporation of INPC data may identify 
instances where redundant testing takes place, another 
practical example of the value of health information 
exchange. 
Conclusions 
Electronic clinical data from outside the VA informs 
a more complete understanding of both the quality 
and cost of care delivered to patients in the VA.  Our 
local project experience with data linkage and 
information exchange mirrors the experience 
nationally.  Currently, there is no regular mechanism 
for information exchange of real-time data between 
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the VA and outside organizations.  Demonstration 
projects such as ours lay the groundwork for 
establishing the processes, feasibility, and value of 
such data linkages.  Pursuing opportunities for live 
health information exchange between the VA (or 
Department of Defense) and RHIOs would be 
promising future activity. 
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